Medicare Part B spent $9.3 billion on laboratory tests in 2021, a recent report from the Office of Inspector General (OIG) found. This represents a 17% increase from 2020, when spending was at $8 ...

Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...

A cross-sectional analysis of Medicare beneficiaries found that one in six beneficiaries used telehealth between 2021 and 2023, with nearly half of all mental health visits conducted virtually. The ...

Nation-wide rapid declines in prescription opioid dispensing gave rise to concerns regarding restricted access to effective pain management for patients with cancer-related pain. One important ...

Numerous studies show that employer plans pay providers significantly more than Medicare, but less is known about prices in nongroup plans sold both on and off the Marketplaces established by the ...